Paula A Sepulveda-Beltran (Paula A Sepulveda Beltran)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Neuropathic Pain

Top Venues

Ocular immunology and inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
David Valdés-Arias, Elyana Vittoria Tessa Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease. Drugs 84 (5) (2024)
Piero Carletti, Paula A Sepulveda-Beltran, Harry Levine, Sander R Dubovy, Victor L Perez, Guillermo Amescua
Long-Term Comprehensive Management of Bilateral Limbal Stem Cell Deficiency Secondary to Severe Chemical Burn: 10 Years of Follow-Up. Ocular immunology and inflammation (2022)